Adults with SBMA have elevated levels of NfL and GFAP, two biomarkers for nerve damage, in their cerebrospinal fluid, a study ...

Can BTK inhibitors finally move the needle in progressive MS? Dr Robert Fox joins Dr Anne Cross to unpack the results of the ...

The company's laboratory-developed test (LDT) for neurofilament light chain (NfL) also gained New York State approval as part of the permitting process.

In Huntington’s disease research, biomarkers are the secret weapon for spotting treatment effects. A new blood study uncovers two proteins, CAP1 and CAPZB, that, with additional work, could help track ...

Transthyretin amyloidosis (ATTR) is caused by the misfolding and aggregation of the transthyretin (TTR) protein, leading to ...

Scientists discovered a genetic marker that predicts before MS therapy whether glatiramer acetate or interferon is likely to ...

A liquid fat supplement, triheptanoin, can reverse mitochondrial dysfunction and cell death in patients with the degenerative ...

Votoplam (PTC518) for Huntington's Disease shows promising phase 2 results; a key FDA meeting in Q4 2025 could enable ...

Clene Inc. plans to submit a New Drug Application (“NDA”) for lead candidate CNM-Au8® in ALS by year-end 2025. <li /> FDA meet ...

Myelin biology and repair refers to the science of myelin physiology, manufacture, and how myelin damage in either the peripheral or central nervous systems can be repaired. Myelin – produced by ...

A recent eGastroenterology review by Professor Intissar Anan highlights major breakthroughs in transthyretin amyloidosis ...

For those on the drug for 24 months, there was also a dose-dependent reduction in neurofilament light chain (NfL) protein, another HD biomarker.